Edgewise Therapeutics Inc. (Nasdaq: EWTX) has promoted Behrad Derakhshan, formerly the Boulder-based muscle disease biopharmaceutical company’s chief business officer, to chief operating officer, and ...
BOULDER, Colo. - Edgewise Therapeutics Inc. (NASDAQ:EWTX), a biopharmaceutical company focused on muscle disease treatment ...
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced key changes to its executive team that will strengthen its leadership and sharpen the Company's focus ...
Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the ...
Diese Führungsänderungen treten sofort in Kraft und spiegeln Edgewise's Engagement wider, seine Pipeline von Therapien für schwere Muskelerkrankungen voranzutreiben, einschließlich seines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback